FOI release

Freedom of Information responses from the MHRA - week commencing 19 April

Medicines and Healthcare products Regulatory Agency (MHRA) responses to freedom of information (FOI) requests for week commencing 19 April 2021

• From: Medicines and Healthcare products Regulatory Agency
• Published: 28 May 2021

Documents

Freedom of Information request about drug analysis profiles (FOI-21-076)

HTML

Freedom of Information request about he number of people who post COVID infection developed a thrombus events (FOI-21-277)

HTML

Freedom of Information request about the assessment report for the indication of “symptomatic treatment of severe sialorrhea” for Glycopyrronium Bromide 1mg Tablets (FOI-21-280))

HTML

Freedom of Information request about COVID-19 (FOI-21-281)

HTML

Freedom of Information request for the COV 006 study (FOI-21-282)

HTML

FOI-21-282

PDF, 633 KB, 2 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Freedom of Information request about results/details of the identification and isolation of the Covid19 virus (FOI-21-292)

HTML

Freedom of Information request about the safety of ethylene oxide (EO) and its use to sterilize the swabs used in lateral flow tests (FOI-21-294)

HTML

Freedom of Information request about safe thresholds of ethylene oxide residue on NHS Covid Lateral Flow (LFT) test swabs currently distributed by the NHS (FOI-21-300)

HTML

Freedom of Information request about COVID-19 vaccines and Phase 4 safety long term, and monitoring births (FOI-21-311)

HTML

Freedom of Information request about telephone system contract information (FOI-21-312)

HTML

Freedom of Information request about adverse drug reactions (ADR) (FOI-21-313)

HTML

Freedom of Information request the authorisation of the Pfizer/BioNTech and the Oxford/AstraZeneca vaccines (FOI-21-322)

HTML

Freedom of Information request about ADR figures within Prince Philip Hospital for the years 2018, 2019 and 2020 (FOI-21-339)

HTML

Freedom of Information request about COVID-19 testing (FOI-21/355)

HTML

Freedom of Information request the number of intraocular lenses of any make or model reported to the MHRA for any reason (FOI-21-388)

HTML

Freedom of Information request about Camcolit 400 mg, controlled release Lithium Carbonate and Priadel 400mg Prolonged Release Tablets (FOI-21-432)

HTML

Details

See the MHRA FOI disclosure log.

See all FOI responses from the MHRA for 2021.

Published 28 May 2021